PDS Biotechnology Corp Proceeds from Issuance of Debt
PDS Biotechnology Corp (PDSB) reported Proceeds from Issuance of Debt of $3.00 million for the 9-month period ending 2015-09-30, per its 10-Q filed 2015-11-06.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfDebt · last filed 2015-11-06
- 2015-09-30: Proceeds from Issuance of Debt 9 month $3.00M.
- 2014-09-30: Proceeds from Issuance of Debt 9 month $3.00M.
| Period end | Proceeds from Issuance of Debt 9 month |
|---|---|
| 2015-09-30 | $3.00M 10-Q · filed 2015-11-06 |
| 2014-09-30 | $3.00M 10-Q · filed 2015-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |